Morgan Stanley Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $85
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Dara Mohsenian has maintained an 'Overweight' rating on Colgate-Palmolive (NYSE:CL) but lowered the price target from $89 to $85.
October 30, 2023 | 2:27 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley has maintained an 'Overweight' rating on Colgate-Palmolive but lowered the price target from $89 to $85.
The news is directly related to Colgate-Palmolive. While the 'Overweight' rating indicates a positive outlook, the lowering of the price target might create some uncertainty among investors, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100